Feasibility of transcatheter aortic valve implantation without balloon pre-dilation: a pilot study.

[1]  M. Mack,et al.  Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, The Journal of thoracic and cardiovascular surgery.

[2]  P. Serruys,et al.  2-year follow-up of patients undergoing transcatheter aortic valve implantation using a self-expanding valve prosthesis. , 2011, Journal of the American College of Cardiology.

[3]  Pascal Vranckx,et al.  Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. , 2011, Journal of the American College of Cardiology.

[4]  S. Pocock,et al.  Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. , 2010, The New England journal of medicine.

[5]  E. Tuzcu,et al.  "SOURCE" of enthusiasm for transcatheter aortic valve implantation. , 2010, Circulation.

[6]  Thomas Walther,et al.  Thirty-Day Results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry: A European Registry of Transcatheter Aortic Valve Implantation Using the Edwards SAPIEN Valve , 2010, Circulation.

[7]  P. Wenaweser,et al.  Transcatheter aortic valve implantation: predictors of procedural success--the Siegburg-Bern experience. , 2010, European heart journal.

[8]  Fabian Nietlispach,et al.  Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. , 2010, Journal of the American College of Cardiology.

[9]  J. Ivanov,et al.  VALVULAR AND STRUCTURAL HEART DISEASES Original Studies Transcatheter Aortic Valve Implantation For High Risk Patients With Severe Aortic Stenosis Using the Edwards Sapien Balloon-Expandable BioProsthesis: A Single Centre Study With Immediate and Medium-Term Outcomes , 2010 .

[10]  T. Felderhoff,et al.  Progress and Current Status of Percutaneous Aortic Valve Replacement: Results of Three Device Generations of the CoreValve Revalving System , 2008, Circulation. Cardiovascular interventions.

[11]  P. Serruys,et al.  Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. , 2008, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[12]  S. Möhlenkamp,et al.  Revival of an old method with new techniques: balloon aortic valvuloplasty of the calcified aortic stenosis in the elderly , 2008, Clinical Research in Cardiology.

[13]  Thomas Walther,et al.  Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. , 2007, Journal of the American College of Cardiology.

[14]  M. Cheitlin.  Percutaneous Aortic Valve Implantation Retrograde From the Femoral Artery , 2007 .

[15]  Thomas Felderhoff,et al.  Percutaneous Implantation of the CoreValve Self-Expanding Valve Prosthesis in High-Risk Patients With Aortic Valve Disease: The Siegburg First-in-Man Study , 2006, Circulation.

[16]  A. Cribier,et al.  Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. , 2006, Journal of the American College of Cardiology.

[17]  Thomas Felderhoff,et al.  First report on a human percutaneous transluminal implantation of a self‐expanding valve prosthesis for interventional treatment of aortic valve stenosis , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[18]  Assaf Bash,et al.  Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. , 2004, Journal of the American College of Cardiology.

[19]  Assaf Bash,et al.  Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis: First Human Case Description , 2002, Circulation.

[20]  F. Anselme,et al.  Balloon aortic valvuloplasty in elderly patients at high risk for surgery, or inoperable. Immediate and mid-term results. , 1995, European heart journal.

[21]  I. Palacios,et al.  Three‐Year Outcome After Balloon Aortic Valvuloplast: Insights Into Prognosis of Valvular Aortic Stenosis , 1994, Circulation.

[22]  L. Wilkins.  Percutaneous Balloon Aortic Valvuloplasty: Acute and 30‐Day Follow‐up Results in 674 Patients From the NHLBI Balloon Valvuloplasty Registry , 1991, Circulation.

[23]  Nadir Saoudi,et al.  PERCUTANEOUS TRANSLUMINAL VALVULOPLASTY OF ACQUIRED AORTIC STENOSIS IN ELDERLY PATIENTS: AN ALTERNATIVE TO VALVE REPLACEMENT? , 1986, The Lancet.

[24]  Z. Lababidi,et al.  Percutaneous balloon aortic valvuloplasty. , 1986 .